Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14910 |
CD161
NKR-P1A |
Others | Others |
CD161 is a potent, selective, and orally bioavailable BET bromodomain inhibitor (IC50s: 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2) with good anticancer activity. |